Navigation Links
Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
Date:4/25/2012

SUNNYVALE, Calif., April 25, 2012 /PRNewswire/ -- Fujitsu Semiconductor America (FSA) and an impressive group of partner companies will highlight innovative radio-frequency identification (RFID) solutions using Fujitsu's Ferroelectric Random Access Memory (FRAM) technology at Interphex 2012 (booth 2430). Fujitsu and its partners will feature radiation-resistant FRAM RFID solutions suitable for medical and pharmaceutical applications where gamma sterilization is used. Interphex 2012 will be May 1-3 at the Javits Center in New York City.

(Logo: http://photos.prnewswire.com/prnh/20120412/SF85935LOGO-b)

Joining Fujitsu at Interphex will be Verigenics (http://www.verigenics.com), Vizinex RFID (http://www.vizinexrfid.com) and Toppan Printing Co., Ltd. (www.toppan.co.jp).

"Fujitsu's high-performance FRAM technology can track medical devices and supplies, even through the gamma sterilization process," said Tong Swan Pang, senior manager of marketing at Fujitsu Semiconductor America. "The partner companies joining us at Interphex 2012 have integrated Fujitsu's FRAM into their products to provide radiation-resistant, high-performance RFID solutions for use in the medical, bio-processing, and pharmaceutical industries."

For more information about the conference and Fujitsu's FRAM technology, please visit http://www.fujitsu.com/us/semiconductors/interphex2012.html.

How FRAM RFID Can Help Medical and Pharmaceutical Professionals

FRAM is a high-performance, low-power and non-volatile memory that combines the benefits of non-volatile memories (Flash and EEPROM) with high-speed RAM (SRAM and DRAM). Compared to other nonvolatile memories, key advantages of FRAM include a fast read / write speed (~150 nanoseconds), low power consumption (more than 200 times lower than EEPROM), and high endurance (10 billion read/write cycles). This tamper-resistant, secure memory is not affected by magnetic fields. Most important for medical and pharmaceutical applications, FRAM is radiation-resistant. FRAM data is protected against up to 50kGy gamma ray sterilization, more than twice the typical dosage used in medical applications.

Combined with RFID technologies, FRAM simplifies the task of assuring that vital medical and pharmaceutical products are safe. FRAM overcomes the serious limitation of conventional RFID tags that use EEPROM, a memory technology that can be compromised by small doses of radiation. Since the ferroelectric material at the heart of Fujitsu's FRAM technology is inherently radiation hardened, it can easily withstand the typical gamma ray sterilization. 

Fujitsu recently published a technical paper detailing how FRAM RFID can improve the medical sterilization process. It is available for free download from "EE Times": http://www.eetimes.com/electrical-engineers/education-training/tech-papers/4369829/How-FRAM-RFID-Improves-the-Medical-Sterilization-Process

The Fujitsu FerVID FRAM RFID Family

Fujitsu offers HF and UHF RFID products with embedded FRAM that outperforms conventional EEPROM/Flash based RFID chips and is better suited for medical and pharmaceutical applications. The FerVID FRAM RFID family, unlike conventional RFID tags, features high speed data transfer rate for both reading and writing over long distances.

The FerVID FRAM RFID family products are ISO/IEC15693, ISO/IEC 18000-3 or EPCglobal Class 1 Generation 2 compliant. Fujitsu offers wafers, sawn wafers or packaged chips. Derivatives with combined contactless and contact-based SPI interfaces are available. Fujitsu's RFID products come with capacities ranging from 256 Bytes to 64k Bytes of FRAM.

For more information about FRAM solutions available from Fujitsu, please visit http://us.fujitsu.com/semi/fram.

About Fujitsu Semiconductor America, Inc.

Fujitsu Semiconductor America, Inc. (FSA) is a leading designer and developer of innovative semiconductor products and solutions for new generations of consumer, communications, automotive and industrial products. FSA provides a comprehensive portfolio of high-quality, reliable semiconductor products and services throughout North and South America. Founded in 1979 and headquartered in Sunnyvale, California, Fujitsu Semiconductor America (formerly Fujitsu Microelectronics America) is a wholly owned subsidiary of Fujitsu Semiconductor Limited (FSL), Japan.

For product information, visit the company's website at http://us.fujitsu.com/semi, e-mail FSA_inquiry@us.fujitsu.com or call 1-800-866-8608. For company news and updates, connect with FSA on Twitter at http://twitter.com/FujitsuSemiUS or YouTube at http://www.youtube.com/FujitsuSemiUS.

All product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and subject to change without advance notice.

 

 


'/>"/>
SOURCE Fujitsu Semiconductor America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011
2. Blue Belt Technologies to Showcase Navio™ PFS System at CAOS UK 2012 Conference in Glasgow, UK
3. Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. MedPlasts Pessary Balloon Manufacture Showcases Multi-Function Technical Mastery
6. GenturaDx to Present at the Biotech Showcase Conference
7. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
8. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
9. Ikaria® to Present at Biotech Showcase™ 2012
10. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
11. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 ... that positive Phase 1 clinical data for Nektar,s lead ... (RCC) were presented at ASCO GU 2017.  NKTR-214 is ... T cells and Natural Killer (NK) cell abundance directly ... on these immune cells.  The results were presented by ...
(Date:2/17/2017)... 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, ... global ablation technologies market is expected to grow at a CAGR ... market is expected to grow at a CAGR of 9.5% from ... and $9.05bn in 2026. ... How this report will benefit you Read on to ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology:
(Date:2/17/2017)... , ... February 17, 2017 , ... ... and financial planning assistance to families and business owners in and around the ... charity drive to help prevent all forms of domestic violence. , There are ...
(Date:2/16/2017)... New York, New York (PRWEB) , ... February ... ... hard work and determination. After what took over 10 years of research, development ... disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ...
(Date:2/16/2017)... , ... February 17, 2017 , ... Teaching nursing care ... program, now in development. ACE.P (pediatrics) is being created with the support of the ... of Vulnerable Populations , ACE.P will address what has been identified as a critical ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
(Date:2/16/2017)... Arizona (PRWEB) , ... February 16, 2017 , ... ... (623) 242-5247, doegedevelopment.com/contact/ , doegedevelopment.com , David A Doege is ... company specializing in commercial tenant improvements, ground up new builds, design build, and ...
Breaking Medicine News(10 mins):